CRIS
Price
$1.92
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
20.82M
EQ
Price
$0.39
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
14.14M
75 days until earnings call
Interact to see
Advertisement

CRIS vs EQ

Header iconCRIS vs EQ Comparison
Open Charts CRIS vs EQBanner chart's image
Curis
Price$1.92
Change-$0.00 (-0.00%)
Volume$80
Capitalization20.82M
Equillium
Price$0.39
Change-$0.00 (-0.00%)
Volume$173
Capitalization14.14M
CRIS vs EQ Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. EQ commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and EQ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CRIS: $1.92 vs. EQ: $0.39)
Brand notoriety: CRIS and EQ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 0% vs. EQ: 0%
Market capitalization -- CRIS: $20.82M vs. EQ: $14.14M
CRIS [@Biotechnology] is valued at $20.82M. EQ’s [@Biotechnology] market capitalization is $14.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileEQ’s FA Score has 1 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • EQ’s FA Score: 1 green, 4 red.
According to our system of comparison, EQ is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 5 TA indicator(s) are bullish while EQ’s TA Score has 4 bullish TA indicator(s).

  • CRIS’s TA Score: 5 bullish, 5 bearish.
  • EQ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EQ is a better buy in the short-term than CRIS.

Price Growth

CRIS (@Biotechnology) experienced а -4.00% price change this week, while EQ (@Biotechnology) price change was -1.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

EQ is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRIS($20.8M) has a higher market cap than EQ($14.1M). CRIS YTD gains are higher at: -37.255 vs. EQ (-48.530). EQ has higher annual earnings (EBITDA): -4.46M vs. CRIS (-44.56M). EQ has more cash in the bank: 25.9M vs. CRIS (20.9M). EQ has less debt than CRIS: EQ (497K) vs CRIS (3.26M). EQ has higher revenues than CRIS: EQ (45.9M) vs CRIS (10.3M).
CRISEQCRIS / EQ
Capitalization20.8M14.1M148%
EBITDA-44.56M-4.46M998%
Gain YTD-37.255-48.53077%
P/E RatioN/AN/A-
Revenue10.3M45.9M22%
Total Cash20.9M25.9M81%
Total Debt3.26M497K656%
FUNDAMENTALS RATINGS
CRIS vs EQ: Fundamental Ratings
CRIS
EQ
OUTLOOK RATING
1..100
355
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
6194
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for CRIS (63). This means that EQ’s stock grew somewhat faster than CRIS’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that EQ’s stock grew similarly to CRIS’s over the last 12 months.

EQ's SMR Rating (92) in the Biotechnology industry is in the same range as CRIS (99). This means that EQ’s stock grew similarly to CRIS’s over the last 12 months.

CRIS's Price Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for EQ (94). This means that CRIS’s stock grew somewhat faster than EQ’s over the last 12 months.

CRIS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EQ (100). This means that CRIS’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISEQ
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEOG6.22N/A
N/A
Neogen Corp
ASUR9.52N/A
N/A
Asure Software
BAH128.42N/A
N/A
Booz Allen Hamilton Holding Corp
AORT28.55N/A
N/A
Artivion
ICU1.28-0.02
-1.54%
SeaStar Medical Holding Corp

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with RCKT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
N/A
RCKT - CRIS
38%
Loosely correlated
N/A
ABEO - CRIS
37%
Loosely correlated
N/A
ROIV - CRIS
35%
Loosely correlated
+0.27%
VTGN - CRIS
34%
Loosely correlated
N/A
ORMP - CRIS
34%
Loosely correlated
N/A
More

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MTNB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
N/A
MTNB - EQ
38%
Loosely correlated
N/A
IMNM - EQ
33%
Poorly correlated
+6.82%
PRQR - EQ
28%
Poorly correlated
-1.74%
WVE - EQ
26%
Poorly correlated
N/A
MURA - EQ
24%
Poorly correlated
N/A
More